Billionaire Biohacker Claims 'Longevity Pill' Saved Dying Dog, Human Trials On The Cards

Death and taxes are the only two inevitable events in life. That is not the view held by billionaire biohacker, Bryan Johnson. The tech mogul is known for his $2 million-a-year anti-ageing regimen, which he calls the Blueprint protocol, attempting to make him look 18 years old. In order to do this, he has evolved into the “most measured human,” with medical professionals continuously monitoring every facet of his well-being and creating an exceptional daily schedule that he generously shares with the rest of us. He recently shared about a “longevity pill” that he claimed extended the life of an old German Shepherd.

Additionally, he disclosed in the post that the researchers behind this novel drug want to move on with human clinical trials, which might lead to a major advancement in human longevity.

Posting a video on X, he wrote, “Longevity pill saved the life of an old (80-90 yr human equivalent), ill German Shepherd. Human trials next. The pill stabilises telomeres, the caps holding tips of our DNA from getting loose.” A telomere is a section of repeating DNA sequences found at the end of a chromosome. Telomeres prevent chromosomal ends from fraying or tangling.

The video, which has received over 3 lakh views, showed the dog’s transformation from being terminally sick to a healthy pup once more.

Naturally, the comments section had a lot of questions.

A user asked, “What happens when “Don’t Die” is achieved? How many continents will be needed to house the people?”

Another user enquired, “How long can they extend the lifespan of dogs now?”

Meanwhile, a third user said, “When could this hit the market for humans? What would the price be? Any estimate?”

Yet another user mentioned, “What’s in the pill? Everything around this is so secretive.”

After taking the medication, Zeus, a 12-year-old German Shepherd with terminal cancer, recovered completely, while Benson, another ageing dog, was able to walk again, according to ABC7. Currently, 10 dogs are taking part in the canine study.

As per the research by Telomir Pharmaceuticals and Cleveland Clinic, this medication may soon be beneficial to humans as well, possibly leading to an enormous jump in the average length of healthy lifespans.